These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37517581)

  • 1. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
    Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
    Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions.
    Braga CL; da Silva LR; Santos RT; de Carvalho LRP; Mandacaru SC; de Oliveira Trugilho MR; Rocco PRM; Cruz FF; Silva PL
    Cytotherapy; 2022 Dec; 24(12):1211-1224. PubMed ID: 36192337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
    Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Sharma M; Bellio MA; Benny M; Kulandavelu S; Chen P; Janjindamai C; Han C; Chang L; Sterling S; Williams K; Damianos A; Batlahally S; Kelly K; Aguilar-Caballero D; Zambrano R; Chen S; Huang J; Wu S; Hare JM; Schmidt A; Khan A; Young K
    Stem Cells Transl Med; 2022 Aug; 11(8):828-840. PubMed ID: 35758326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism.
    Wan M; Lu C; Liu Y; Luo F; Zhou J; Xu F
    Respir Res; 2023 Sep; 24(1):233. PubMed ID: 37759281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
    Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.
    Dabrowska S; Andrzejewska A; Strzemecki D; Muraca M; Janowski M; Lukomska B
    J Neuroinflammation; 2019 Nov; 16(1):216. PubMed ID: 31722731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Muhammad SA; Abbas AY; Saidu Y; Fakurazi S; Bilbis LS
    Biochimie; 2020 Jan; 168():156-168. PubMed ID: 31678635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis.
    Tieu A; Hu K; Gnyra C; Montroy J; Fergusson DA; Allan DS; Stewart DJ; Thébaud B; Lalu MM
    J Extracell Vesicles; 2021 Oct; 10(12):e12141. PubMed ID: 34596349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-Derived Mesenchymal Stromal Cells Under Hypoxia: Changes in Extracellular Vesicles Secretion and Improvement of Renal Recovery after Ischemic Injury.
    Collino F; Lopes JA; Corrêa S; Abdelhay E; Takiya CM; Wendt CHC; de Miranda KR; Vieyra A; Lindoso RS
    Cell Physiol Biochem; 2019; 52(6):1463-1483. PubMed ID: 31099507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
    Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characteristics and Function of Small Extracellular Vesicles Derived from Human Bone Marrow and Umbilical Cord Mesenchymal Stromal Cells Are Influenced by Cell Culture Conditions.
    Naskou MC; Cochran A; Darzenta N; Golan ME; Stice SL; Martin DR
    Stem Cells Dev; 2024 Mar; 33(5-6):117-127. PubMed ID: 38164117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.